Theme news

SHERIDAN, WYOMING - November 14, 2025 - Koelnmesse has secured another major reputation milestone, earning first place in the "Most Desirable Employer 2025" ranking for German trade fair venues. The award, issued by the F.A.Z. Institute in cooperation with ServiceValue, highlights Koelnmesse's strong employer reputation based on workplace culture, career development, and long-term employee satisfaction.

Comprehensive Reputation Study Positions Koelnmesse as Industry Leader

The new ranking draws upon a wide-ranging analysis of public online data and structured employer surveys. For the category of "trade fair locations," Koelnmesse achieved the highest score in Germany, building on its previous achievements after being named "Company of the Year" twice in a row by FOCUS MONEY and DEUTSCHLAND TEST.

SHERIDAN, WYOMING - November 14, 2025 - Koelnmesse has once again secured its position as one of Germany's most trusted and best-performing trade fair operators, earning the 2025 "Company of the Year" award from FOCUS MONEY and DEUTSCHLAND TEST. The recognition, based on four AI-supported reputation studies conducted throughout 2024, reinforces Koelnmesse's standing as a benchmark within the country's competitive exhibition landscape.

Bolded Subheadings Begin Below

Reputation Analysis Confirms Strong Industry Position

SHERIDAN, WYOMING - November 13, 2025 - Koelnmesse is deepening its position as one of the world's most internationally active trade fair organizers, announcing multiple successful show launches in Saudi Arabia and preparing to debut ORGATEC WORKSPACE Saudi Arabia on 16 September 2025. The expansion reflects growing demand for specialized B2B events in high-growth global markets and underscores Koelnmesse's outbound strategy to strengthen brands beyond Cologne.

Strong New Launches Signal Momentum in Saudi Arabia

SHERIDAN, WYOMING - November 14, 2025 - Rapid prototyping and digital on-demand manufacturing are becoming indispensable pillars in the medical device industry as manufacturers race to accelerate development cycles, reduce costs, and bring high-performance devices to market faster. With rising demand for personalized medical solutions and increasingly complex regulatory expectations, companies are turning to advanced prototyping partners to validate designs earlier, improve manufacturability, and support real-world clinical readiness.

Bolded H5 subheadings start below

Innovation Driving Faster Medical Device Development

SHERIDAN, WYOMING - November 14, 2025 - Ricoh and Neat have formed a global partnership aimed at redefining the future of workplace collaboration through integrated, AI-driven audiovisual solutions. Neat, a global leader in professional AV technology, will join forces with Ricoh-one of the world's foremost AV integrators-to expand Ricoh's high-end meeting-room portfolio and deliver enhanced workplace-experience capabilities to customers worldwide. The agreement is signed at Neat's Mastery Level, the highest tier of its global partner program.

Expanding Premium Meeting-Room Capabilities Through Integrated AV Services

SHERIDAN, WYOMING - November 14, 2025 - Shanghai Lingee Sensor Technology has unveiled a new generation of ultra-miniature, high-precision temperature sensors engineered to improve thermal management in brushless and frameless motors. As European manufacturers across robotics, consumer electronics, medical devices, and home appliances continue to demand higher power density, longer service life, and faster system responsiveness, Lingee's platform is emerging as a compelling component-level innovation that strengthens supply chain reliability and performance.

SHERIDAN, WYOMING - November 13, 2025 - Shanghai Lingee Sensor Technology is strengthening its position in the global motor supply chain with a newly engineered miniature temperature sensor designed specifically for brushless and frameless motors. As electric motors proliferate across robotics, consumer electronics, medical devices and advanced home appliances, the company's innovation delivers critical improvements in precision, safety and high-temperature reliability.

A New Class of Ultra-Compact, High-Precision Sensors

Lingee's latest sensor is engineered for environments where heat buildup quickly impacts motor lifespan, efficiency and control accuracy. Measuring only 0.55 mm with a recommended installation dimension of 0.88 mm, the device allows manufacturers to integrate precise thermal monitoring even in tightly packaged motor designs.

The sensor system provides:

SHERIDAN, WYOMING - November 13, 2025 - Dentsply Sirona is strengthening its long-term commitment to increasing oral-health access for U.S. veterans, deepening its partnership with Dental Lifeline Network (DLN) and activating employee-driven support initiatives across the country. The renewed collaboration aligns with the company's global sustainability strategy and reflects a growing corporate focus on social-impact programs that directly address care gaps in underserved populations.

Strengthening a Decades-Long Collaboration

Dentsply Sirona and DLN have worked together since 1999, forming one of the dental industry's most enduring corporate-nonprofit collaborations. Entering its 26th year, the partnership includes direct financial support, in-kind product donations and professional-volunteer mobilization through Dentsply Sirona's VETERANS@DS employee resource group.

SHERIDAN, WYOMING - November 13, 2025 - Heidelberger Druckmaschinen AG (HEIDELBERG) has delivered a notably stronger first half of fiscal year 2025/2026, reporting higher sales, sharply improved profitability and continued strategic momentum across its printing, packaging and technology businesses. The results signal renewed financial resilience as the company advances its transformation strategy amid ongoing macroeconomic pressure.

Sales Growth Across Core Markets

During the first six months (April 1-September 30, 2025), HEIDELBERG generated €985 million in sales, an 8% increase over the previous year's period. Europe and Asia were standout regions, contributing significantly to the uplift. The second quarter alone delivered €519 million in revenue-up from €466 million in the first quarter-despite negative currency impacts totaling around €12 million.

SHERIDAN, WYOMING - November 13, 2025 - Amperfied, the e-mobility subsidiary of Heidelberger Druckmaschinen AG (HEIDELBERG), has secured one of Germany's most significant corporate charging-infrastructure contracts of the year, taking over the migration and long-term operational management of Siemens Energy's nationwide EV charging network. The agreement positions Amperfied as a leading systems integrator for enterprise-scale charging operations as demand for reliable, multi-site electrification continues to accelerate.

Modernizing a Complex Charging Environment

SHERIDAN, WYOMING - November 13, 2025 - Dentsply Sirona and Rapid Shape have jointly advanced digital denture manufacturing by validating the Lucitone Digital Print Denture System across Rapid Shape's D50+, D90+ and PRO 20 3D printers. The collaboration expands access to high-strength printable denture materials and fully automated workflows, helping dental laboratories scale production as technician shortages and patient demand intensify globally.

A Major Expansion of Validated Digital Denture Workflows

SHERIDAN, WYOMING - November 13, 2025 - Teleste has completed a major upgrade to the main outdoor passenger information display at Helsinki Central Railway Station, bringing next-generation RGB LED technology to Finland's busiest transportation hub. The deployment enhances real-time communication for up to 300,000 daily travelers and strengthens Teleste's long-standing partnership with national traffic management authority Fintraffic.

SHERIDAN, WYOMING - November 13, 2025 - Dentsply Sirona celebrated two decades of its Global Clinical Case Contest (GCCC), honoring dental students who demonstrated exceptional restorative dentistry skills and a growing mastery of digital workflows. The anniversary event highlighted how the company continues to invest in early-career clinicians, raising global standards in esthetic and functional dentistry through hands-on education, mentorship and modern restorative technologies.

A Milestone Year for an International Training Platform

SHERIDAN, WYOMING - November 13, 2025 - ARCHITECT@WORK (A@W) will return to Messe Düsseldorf on December 3-4, 2025, with a sharpened focus on sustainable building and architectural transformation. The curated event, long regarded as a must-attend platform for specifiers, architects, and interior designers, is positioning its 9th Düsseldorf edition around the industry's most urgent mandate: repurposing, upgrading, and decarbonizing the built environment.

SHERIDAN, WYOMING - November 13, 2025 - Pfizer has completed its $7 billion acquisition of Metsera, securing a set of differentiated obesity and cardiometabolic candidates as regulatory momentum accelerates around metabolic disease innovation in the United States. The deal positions Pfizer at the center of one of the most politically scrutinized and fastest-growing therapeutic markets, as federal leaders push for expanded access and a stronger domestic pipeline in obesity care.

SHERIDAN, WYOMING - November 13, 2025 - As the TrumpRx platform approaches launch in early 2026, U.S. drugmakers are rolling out targeted direct-to-consumer pricing for a carefully chosen mix of dermatology, respiratory, cardiovascular, immunology, and metabolic products. While the discounts generate attention, analysts say their commercial impact varies sharply by drug class, revenue cycle, and therapeutic demand-revealing a strategic pattern rather than a broad affordability shift.

Discounting Patterns Reveal Manufacturers' Portfolio Priorities
Pfizer, AstraZeneca, Amgen, Bristol Myers Squibb, Novo Nordisk, and Lilly have each chosen different subsets of products for deep DTC price cuts. Across these offerings, a clear pattern emerges: brands with declining growth, approaching patent expirations, or limited payer friction are overrepresented.

SHERIDAN, WYOMING - November 13, 2025 - Major pharmaceutical companies are rapidly rolling out direct-to-consumer (DTC) pricing programs ahead of the federal TrumpRx platform's debut in early 2026, signaling a shift in commercial strategy as manufacturers seek to bypass traditional intermediaries and regain control of how patients access branded therapies. Yet analysts warn that these channels-despite deep headline discounts-may offer only marginal financial relief to most patients and are unlikely to dent overall U.S. drug spending.

SHERIDAN, WYOMING - November 13, 2025 - As the federal government prepares to launch its TrumpRx direct-to-consumer platform in early 2026, U.S. drugmakers are accelerating their own discount initiatives in anticipation of sweeping pricing reforms tied to the Most Favored Nation (MFN) framework. Yet analysts and health economists warn that these programs-ranging from discounted dermatology creams to multi-billion-dollar GLP-1 therapies-may have limited influence on overall spending, with most insured patients unlikely to shift away from existing payer pathways.

SHERIDAN, WYOMING - November 13, 2025 - Drug manufacturers are urging the FDA to broaden its proposed PreCheck program beyond new factory construction, warning that excluding existing facilities could slow U.S. efforts to expand pharmaceutical production capacity. At a recent agency meeting, representatives from companies spanning gene therapy, generics, and biologics argued that PreCheck's current scope overlooks the fastest route to alleviating drug shortages and strengthening domestic supply chains.

Early-Stage Regulatory Support Designed Only for New Sites
PreCheck was introduced to streamline the regulatory oversight of newly built manufacturing plants, giving participating companies earlier FDA engagement well before their first commercial product application. The program is meant to make U.S. construction more attractive by reducing uncertainty and aligning expectations early in the buildout process.

SHERIDAN, WYOMING - November 13, 2025 - In a sweeping regulatory shift with major implications for women's health providers, pharmaceutical manufacturers, and payers, the FDA has removed the black box warning from all hormone replacement therapy (HRT) products. The reversal ends a 22-year stance shaped by the early 2000s Women's Health Initiative (WHI) trial and opens the door to renewed clinical adoption and investment across the growing HRT market.